LRIG3 antibody
-
- Target See all LRIG3 Antibodies
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This LRIG3 antibody is un-conjugated
-
Application
- ELISA, Immunohistochemistry (IHC)
- Cross-Reactivity
- Human
- Purification
- Antigen affinity purification
- Immunogen
- Synthetic peptide of Human LRIG3
- Isotype
- IgG
- Top Product
- Discover our top product LRIG3 Primary Antibody
-
-
- Application Notes
- ELISA:1:1000-1:5000, IHC:1:25-1:100,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
- Alternative Name
- LRIG3 (LRIG3 Products)
- Synonyms
- LRIG3 antibody, lrig3 antibody, GB17149 antibody, LIG3 antibody, 9030421L11Rik antibody, 9130004I02Rik antibody, 9430095K15Rik antibody, mKIAA3016 antibody, RGD1561255 antibody, leucine rich repeats and immunoglobulin like domains 3 antibody, leucine-rich repeats and immunoglobulin-like domains 3 antibody, leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, leucine-rich repeats and immunoglobulin like domains 3 S homeolog antibody, leucine-rich repeats and immunoglobulin like domains 3 antibody, LRIG3 antibody, lrig3 antibody, LOC726128 antibody, lrig3.S antibody, Lrig3 antibody
- Background
-
Background: Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis. Lrig3 was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition of Lrig3 expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.
Aliases: Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody, LIG-3 antibody, LIG3 antibody, LRIG1-3 antibody, Lrig3 antibody, LRIG3_HUMAN antibody
- UniProt
- Q6UXM1
-